Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Pirnay, Jean-Paul" or (type any "bookEditor issueEditor" and editor="Pirnay, Jean-Paul")

Add to list
Evaluating risk, safety and efficacy of novel reproductive techniques and therapies through the EuroGTP II risk assessment tool

Esteve Trias, Martine Nijs, Ioana Adina Rugescu, Francesco Lombardo, Gueorgui Nikolov, Veerle Provoost (UGent) , Annelies Tolpe (UGent) , Nathalie Vermeulen, Zdravka Veleva, Rita Piteira, et al.

(2020) HUMAN REPRODUCTION. 35(8). p.1821-1838
Add to list
- Journal Article
- A1
- open access
Development of a qPCR platform for quantification of the five bacteriophages within bacteriophage cocktail 2 (BFC2)

Hans Duyvejonck (UGent) , Maia Merabishvili (UGent) , Jean-Paul Pirnay, Daniel De Vos, Gilbert Verbeken, Jonas Van Belleghem, Tessa Gryp (UGent) , Julie De Leenheer, Kelly Van der Borght, Leen Van Simaey (UGent) , et al.

(2019) SCIENTIFIC REPORTS. 9.
Add to list
- Journal Article
- A1
- open access
Biological tests carried out on serum/plasma samples from donors of human body material for transplantation : Belgian experience and practical recommendations

Elizaveta Padalko (UGent) , Katrien Lagrou, Marie-Luce Delforge, Hilde Jansens, Nadine Ectors, Jean-Paul Pirnay, Johan Klykens, Etienne Sokal, Ludo Muylle, Agnes Libois, et al.

(2018) CELL AND TISSUE BANKING. 19(4). p.681-695
Add to list
- Journal Article
- A1
- open access
Stability of bacteriophages in burn wound care products

Maia Merabishvili (UGent) , Riet Monserez, Jonas Van Belleghem (UGent) , Thomas Rose, Serge Jennes, Daniel De Vos, Gilbert Verbeken, Mario Vaneechoutte (UGent) and Jean-Paul Pirnay

(2017) PLOS ONE. 12(7).
Add to list
- Miscellaneous
A bacteriophage journey at the European Medicines Agency

Laurent Debarbieux, Jean-Paul Pirnay, Gilbert Verbeken, Daniel De Vos, Maia Merabishvili (UGent) , Isabelle Huys, Olivier Patey, Dirk Schoonjans, Mario Vaneechoutte (UGent) , Martin Zizi, et al.

(2016) FEMS MICROBIOLOGY LETTERS. 363(2).
Add to list
- Book Chapter
Bacteriophages as antibacterial agents : why are we facing an antibiotic crisis and how could bacteriophages be of help?

Jean-Paul Pirnay, Gilbert Verbeken, Mario Vaneechoutte (UGent) , Serge Jennes, Maya Merabishvili, Isabelle Serrano and Daniel De Vos

(2015) The challenging of antibiotic resistance in the development of new therapeutics. In Frontiers in Antimicrobial Agents 1. p.10-32
Add to list
- Miscellaneous
- open access
Access to human tissues for research and product development: from EU regulation to alarming legal developments in Belgium

Jean-Paul Pirnay, Etienne Baudoux, Olivier Cornu, Alain Delforge, Christian Delloye, Johan Guns, Ernst Heinen, Etienne Van den Abbeel (UGent) , Alain Vanderkelen, Caroline Van Geyt (UGent) , et al.

(2015) EMBO REPORTS. 16(5). p.557-562
Add to list
- Journal Article
- A1
- open access
Quality and safety requirements for sustainable phage therapy products

Jean-Paul Pirnay, Bob G. Blasdel, Laurent Bretaudeau, Angus Buckling, Nina Chanishvili, Jason R. Clark, Sofia Corte-Real, Laurent Debarbieux, Alain Dublanchet, Daniel De Vos, et al.

(2015) PHARMACEUTICAL RESEARCH. 32(7). p.2173-2179
Add to list
- Journal Article
- A1
- open access
Characterization of newly isolated lytic bacteriophages active against Acinetobacter baumannii

Maia Merabishvili (UGent) , Dieter Vandenheuvel, Andrew M Kropinski, Jan Mast, Daniel De Vos, Gilbert Verbeken (UGent) , Jean-Paul Noben, Rob Lavigne, Mario Vaneechoutte (UGent) and Jean-Paul Pirnay

(2014) PLOS ONE. 9(8).
Add to list
Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosa

Yves Briers (UGent) , Maarten Walmagh (UGent) , Barbara Grymonprez, Manfred Biebl, Jean-Paul Pirnay, Valerie Defraine, Jan Michiels, William Cenens, Abram Aertsen, Stefan Miller, et al.

(2014) ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 58(7). p.3774-3784

Academic Bibliography

Evaluating risk, safety and efficacy of novel reproductive techniques and therapies through the EuroGTP II risk assessment tool

Development of a qPCR platform for quantification of the five bacteriophages within bacteriophage cocktail 2 (BFC2)

Biological tests carried out on serum/plasma samples from donors of human body material for transplantation : Belgian experience and practical recommendations

Stability of bacteriophages in burn wound care products

A bacteriophage journey at the European Medicines Agency

Bacteriophages as antibacterial agents : why are we facing an antibiotic crisis and how could bacteriophages be of help?

Access to human tissues for research and product development: from EU regulation to alarming legal developments in Belgium

Quality and safety requirements for sustainable phage therapy products

Characterization of newly isolated lytic bacteriophages active against Acinetobacter baumannii

Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosa

Contents

Support

Contact